TScan Therapeutics Ratios (2020-2025) | TCRX

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -2,472.41%-982.01%-390.33%-374.79%-656.67%-497.55%-534.79%-372.21%-483.05%-604.94%-389.02%-763.82%-591.64%-271.99%-5,325.44%-5,906.90%-2,849.09%-5,220.90%-1,571.95%-1,201.30%-1,422.14%
EBIT Margin -2,472.76%-982.39%-390.63%-374.96%-656.80%-497.62%-535.02%-375.89%-492.95%-602.55%-392.12%-781.77%-636.69%-296.17%-5,542.93%-6,364.55%-3,109.82%-5,520.60%-1,669.74%-1,256.60%-1,475.59%
EBITDA Margin -2,472.76%-982.39%-390.63%-374.96%-656.80%-497.62%-535.02%-375.89%-492.95%-602.55%-392.12%-781.77%-636.69%-296.17%-5,542.93%-6,364.55%-3,109.82%-5,520.60%-1,669.74%-1,256.60%-1,475.59%
Operating Margin -2,472.76%-982.39%-390.63%-374.96%-656.80%-497.62%-535.02%-375.89%-492.95%-602.55%-392.12%-781.77%-636.69%-296.17%-5,542.93%-6,364.55%-3,109.82%-5,520.60%-1,669.74%-1,256.60%-1,475.59%
Net Margin -2,472.41%-982.01%-390.33%-374.79%-656.67%-497.55%-534.79%-372.21%-483.05%-604.94%-389.02%-763.82%-591.64%-271.99%-5,325.44%-5,906.90%-2,849.09%-5,220.90%-1,571.95%-1,201.30%-1,422.14%
FCF Margin -2,459.31%-1,098.74%-637.20%-513.27%-600.87%-581.32%-683.71%-376.23%-518.17%-561.78%-421.12%-712.90%169.75%-336.08%-5,295.41%-5,053.54%-2,791.99%-4,255.64%-1,801.84%-1,123.08%-1,349.62%
Efficiency
Assets Average 167.45M196.50M178.16M160.31M158.93M182.27M186.33M245.25M304.15M281.76M256.49M307.85M361.45M359.57M351.91M315.63M280.39M
Equity Average -46.19M-54.98M57.02M167.43M153.24M138.67M124.16M108.05M88.73M134.31M179.78M159.91M136.92M189.09M242.15M235.03M225.59M193.46M160.37M
Invested Capital -42.46M-49.92M-60.03M174.07M160.78M145.69M131.65M116.66M99.43M78.02M190.61M170.07M154.21M129.76M265.56M229.09M240.97M210.20M176.71M144.02M
Asset Utilization Ratio 0.050.050.060.080.080.070.090.060.050.070.060.040.030.010.010.020.03
Leverage & Solvency
Interest Coverage Ratio -82.48-19.13-23.79-25.40-25.20-25.07-32.71-35.83-34.05-46.83-53.39-56.10-53.01
Debt to Equity 0.250.290.380.160.180.200.250.120.130.130.150.180.23
Debt Ratio 0.180.150.170.090.100.110.130.080.090.090.100.110.12
Equity Ratio -0.85-0.460.850.850.870.860.710.500.450.600.580.550.510.680.660.650.630.590.55
Times Interest Earned -82.48-19.13-23.79-25.40-25.20-25.07-32.71-35.83-34.05-46.83-53.39-56.10-53.01
Valuation
Enterprise Value -34.79M-121.50M-106.20M-182.31M-161.41M-140.84M-125.60M-137.31M-120.03M-95.61M-208.84M-215.42M-192.04M-162.78M-297.68M-271.12M-290.11M-251.69M-218.04M-184.45M
Return Ratios
Return on Sales -24.72%-9.82%-3.90%-3.75%-6.57%-4.98%-5.35%-3.72%-4.83%-6.05%-3.89%-7.64%-5.92%-2.72%-53.25%-59.07%-28.49%-52.21%-15.72%-12.01%-14.22%
Return on Capital Employed -0.29%-0.28%-0.36%-0.43%-0.44%-0.40%-0.42%-0.39%-0.33%-0.37%-0.45%-0.41%-0.36%-0.42%-0.43%-0.51%-0.59%
Return on Assets -0.25%-0.25%-0.32%-0.38%-0.39%-0.36%-0.39%-0.33%-0.29%-0.32%-0.38%-0.34%-0.31%-0.35%-0.37%-0.43%-0.50%
Return on Equity 0.61%-0.74%-0.29%-0.37%-0.44%-0.50%-0.61%-0.82%-0.61%-0.49%-0.56%-0.71%-0.55%-0.46%-0.54%-0.58%-0.70%-0.88%